SightfileU.S. market data from official filings

SHOULDER INNOVATIONS INC (SI)

Name: SHOULDER INNOVATIONS INC (SI) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001699350 · EDGAR filings · Updated 2026-06-29

SHOULDER INNOVATIONS INC (SI) has reported institutional ownership of 36.9%, with 58 institutional managers holding positions valued at $110.8M per the latest 13F reporting period.

Institutional ownership

36.9%

Institutional managers

Reported 13F value

$110.8M

Insider activity

53 trans.

$12.0M net buying

Latest updates

2026-06-29 — Insider transaction reported (Form 4)
2026-06-29 — Insider transaction reported (Form 4)
2026-06-29 — Insider transaction reported (Form 4)
2026-06-29 — Insider transaction reported (Form 4)
2026-06-29 — Insider transaction reported (Form 4)
2026-06-29 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SHOULDER INNOVATIONS INC has 58 institutional holders and institutional ownership of 36.9%.

Insider activity

Insiders reported 53 transactions (17 buys, 0 sells) across 12 reporting insiders, with a net reported value of $12.0M.

Related companies

CYBIN INC (HELP) · Onkure Therapeutics Inc (OKUR) · LIFECORE BIOMEDICAL INC (LFCR) · ACUMEN PHARMACEUTICALS INC (ABOS) · ARTIVA BIOTHERAPEUTICS INC (ARTV) · Kalaris Therapeutics Inc (KLRS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-29.